Why the study?
Despite effective medications, uncontrolled blood pressure remains high, and new trials have demonstrated the efficacy and safety of second-generation renal denervation devices.
This consensus document provides expert recommendations for the multidisciplinary evaluation and management of patients with resistant hypertension considered for renal denervation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stabile et al. (2023) conducted a review in Difficult-to-treat arterial hypertension. Renal denervation was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: